B |
2019-08-05 08:21:26.0 |
Gemphire Therapeutics Inc |
GEMP |
NEUROBO PHARMACEUTICALS |
26.0% |
view |
B |
2019-08-02 17:23:23.0 |
Gemphire Therapeutics Inc |
GEMP |
Bisgaier Charles PhD |
10.6% |
view |
S |
2019-02-14 16:06:23.0 |
Gemphire Therapeutics Inc |
GEMP |
Cormorant Asset Management |
0.28% |
view |
S |
2019-02-14 16:01:26.0 |
Gemphire Therapeutics Inc |
GEMP |
Bisgaier Charles PhD |
10.1% |
view |
B |
2019-02-13 17:14:42.0 |
Gemphire Therapeutics Inc |
GEMP |
PFIZER INC |
n/a |
view |
S |
2019-02-06 09:41:39.0 |
Gemphire Therapeutics Inc |
GEMP |
Excel Venture Fund II |
6.8% |
view |
S |
2018-02-13 16:23:44.0 |
Gemphire Therapeutics Inc |
GEMP |
ADAGE CAPITAL PARTNERS GP |
4.22% |
view |
B |
2018-02-13 16:05:33.0 |
Gemphire Therapeutics Inc |
GEMP |
Bisgaier Charles PhD |
13.2% |
view |
S |
2018-02-13 12:59:04.0 |
Gemphire Therapeutics Inc |
GEMP |
Excel Venture Fund II |
8.45% |
view |
B |
2017-03-20 13:11:19.0 |
Gemphire Therapeutics Inc |
GEMP |
ADAGE CAPITAL PARTNERS GP |
5.85% |
view |
B |
2017-02-14 16:37:38.0 |
Gemphire Therapeutics Inc |
GEMP |
Sooch Mina |
8.7% |
view |
B |
2017-02-14 14:10:25.0 |
Gemphire Therapeutics Inc |
GEMP |
Lowenschuss David |
8.7% |
view |
B |
2017-02-13 17:10:34.0 |
Gemphire Therapeutics Inc |
GEMP |
PFIZER INC |
n/a |
view |
B |
2017-02-10 09:26:11.0 |
Gemphire Therapeutics Inc |
GEMP |
Exchange Capital Management |
8.7% |
view |
B |
2017-02-08 12:02:32.0 |
Gemphire Therapeutics Inc |
GEMP |
Excel Venture Fund II |
8.7% |
view |
B |
2016-08-15 16:23:55.0 |
Gemphire Therapeutics Inc |
GEMP |
Cormorant Asset Management |
9.7% |
view |